Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia 26Lymphoma, Non-Hodgkin 18Sarcoma 17Leukemia, Myeloid, Acute 16Hematologic Neoplasms 12Neuroblastoma 11Neoplasms 11Hodgkin Disease 11Myelodysplastic Syndromes 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia, Lymphocytic, Chronic, B-Cell 9Breast Neoplasms 9Burkitt Lymphoma 8Osteosarcoma 6Lymphoma, Large B-Cell, Diffuse 6Multiple Myeloma 5Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Rhabdoid Tumor 4Retinoblastoma 4Recurrence 4Neuroectodermal Tumors, Primitive, Peripheral 4Myeloproliferative Disorders 4Medulloblastoma 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Hematologic Diseases 4

Interventions

rozanolixizumab 10zilucoplan 8efgartigimod alfa 8Rituximab 7Cyclophosphamide 7telitacicept 6fludarabine 6eculizumab 5Prednisone 5ravulizumab 4Pyridostigmine Bromide 4Immunoglobulins, Intravenous 4Hizentra 4Tacrolimus 3Mycophenolic Acid 3HBM9161 3Amifampridine 3thymoglobulin 2inebilizumab 2Prednisolone 2Exercise 2tofacitinib 1tocilizumab 1talquetamab 1satralizumab 1sargramostim 1rhoA GTP-Binding Protein 1remibrutinib 1prednylidene 1iscalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Myasthenia Gravis × Mesna × Clear all
NCT00424489 2018-08-31

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Northwestern University

Phase 1 Terminated
9 enrolled 8 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡